Tag Archives: GSK

FDA and GSK on the Hunt for Stolen Drugs

By George Koroneos | Published: February 24, 2010
Image by Johnny Grim via Flickr We typically don’t get emails from FDA  asking for information about stolen goods with massive bold letters, but that’s what just came into our inbox. Looks like a transport truck containing a mix of GlaxoSmithKline’s pharmaceutical and over-the-counter medications was jacked in Puerto Rico on January 29, and the feds [...]
Posted in FDA, News | Also tagged , , , , , | Leave a comment

HBA Names Woman of the Year

By Oriana Schwindt | Published: February 16, 2010
GSK’s Deirdre Connelly has been named the Healthcare Businesswomen’s Association’s Woman of the Year for 2010. Connelly, who just passed the one-year mark as president of GSK’s North American pharmaceuticals unit, is the 21st woman to win the organization’s “WOTY” award, which comes on the heels of another honor: She was ranked #37 in Fortune’s [...]
Posted in Corporate Responsibility, News, People, leadership | Also tagged , , , | Leave a comment

A Few Words About Diversification

By Julian Upton | Published: February 1, 2010
Guest blog by Dr Brian White, an analyst at Shore Capital. As a result of the feared impact of the patent expiry cliff, the decimation of branded sales by multi-sourced generics and the obstacles erected, especially by managed care in the US, to slow the uptake of branded pharmaceuticals where a generic in the same class [...]
Posted in Europe, Global, Guest Blog, Strategy | Also tagged , , , , , | Leave a comment

Is a Swine Flu Vaccine Backlash on the Cards?

By Julian Upton | Published: July 23, 2009
Image by The Artifex via Flickr The risk of over-production has paid off: world orders for swine vaccines will see billions of dollars in extra revenue for the biggest pharma companies. GlaxoSmithKline, Roche, Sanofi-Aventis, Novartis, and Baxter are all expected to report very healthy first-half earnings as a result of a wealth of government contracts for [...]
Posted in Global, News | Also tagged , , , , , , | Leave a comment

Witty Proposes Price Cap for Poor Nations

By Cassandra Blohowiak | Published: February 18, 2009
GlaxoSmithKline CEO Andrew Witty proposed Friday to slash drug prices in the world’s 50 poorest countries and reinvest 20 percent of the profits in bolstering local health care. In a speech at Harvard Medical School Friday, Witty said drug prices will be capped at 25 percent of what they cost in developed nations. He also [...]
Posted in Corporate Responsibility, Emerging Markets, People | Also tagged , , | Leave a comment